For over a century, CSL Behring has been driven by our promise to patients around the world to deliver life saving therapies. A global leader in the biotherapeutics industry, CSL Behring is passionate about improving the quality of patients' lives and remains committed to the bleeding disorders community, as we deliver a wide range of products for the treatment of rare congenital bleeding disorders, including hemophilia A, hemophilia B, von Willebrand Disease, factor 1 and factor 13 deficiencies. We are proud to partner with the Western Pennsylvania Chapter of the NHF to support fundraising initiatives to offer educational programs and support to the bleeding disorders community. CSL Behring offers exciting opportunities such as the Junior National Championship, a national sports competition for children with bleeding disorders, and is the sole sponsor of the NOW Conference, an weekend-long educational program specifically for individuals and families from across the US living with von Willebrand Disease. For more information about CSL Behring, please visit www.cslbehring.com.